we studied four patients with tumoral hyperprolactinemia and normal ovarian function before and after prolactine levels had become normal with treatment with bromocriptine ( brc ) , a dopamine agonist that inhibits prolactin release .
C0020514
hyperprolactinemia
C0006230
bromocriptine